Arnd Nusch

6.4k citations
51 papers · 768 · 1 hit paper · h-index 14

Impact in

    • Advanced Breast Cancer Therapies
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Renal cell carcinoma treatment
  • Oncology top 10%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology

Papers in

    • Advanced Breast Cancer Therapies 25
    • Lung Cancer Treatments and Mutations 6
    • Renal cell carcinoma treatment 5
    • Cancer Treatment and Pharmacology 9
    • Lung Cancer Research Studies 4

Arnd Nusch

46 papers receiving 757 citations

Arnd Nusch's Hit Papers

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival 2021 · 173 citations
1730+1+3Years since publication50100150

Peers

Arnd Nusch
Comparison fields: 5 of 58
  • Pulmonary and Respiratory Medicine 449
  • Oncology 298
  • Genetics 97
  • Cancer Research 121
  • Pathology and Forensic Medicine 43
Replace Marco Bartolotti with:
Marco Bartolotti Italy
Luís Más Peru
Céline Ferlay France
Chen-Yuan Lin Taiwan
Sarah Sammons United States
Michela Maur Italy
Christopher W. Lee Canada
Christer Svedman United States
Amin H. Nassar United States
Pavlos Papakotoulas Greece
Arnd Nusch relative to Marco Bartolotti Italy Marco Bartolotti's profile →
Citations per field
00.5×7.5×
Marco Bartolotti · 1×
Citations per year

Countries citing papers authored by Arnd Nusch

Since Specialization
Citations

This map shows the geographic impact of Arnd Nusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnd Nusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnd Nusch more than expected).

Fields of papers citing papers by Arnd Nusch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnd Nusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnd Nusch. The network helps show where Arnd Nusch may publish in the future.

Co-authors

The 25 scholars most cited alongside Arnd Nusch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arnd Nusch Line = papers co-authored together Arnd Nusch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
Hit paper breakdown →
2021173
2 200370
3 199257
4 202057
5 201646
6 202342
7 201040
8 202027
9 202125
10 201822
11 201722
12 201919
13 201818
14 200715
15 201812
16 201811
17 201110
18 20149
19 20249
20 20207

About Arnd Nusch

Arnd Nusch is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 51 papers that have together received 768 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (25 papers), Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (9 papers), Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (6 papers), Renal cell carcinoma treatment (5 papers), Lung Cancer Research Studies (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (449 citations), Oncology (298 citations), Genetics (97 citations), Cancer Research (121 citations) and Pathology and Forensic Medicine (43 citations). Arnd Nusch has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Patrick Neven, J. Thaddeus Beck, Norbert Marschner, Guy Jérusalem, Giulia Bianchi, Stephen Chia, Katarína Petráková, Martina Jänicke, Gabe S. Sonke and Luis de la Cruz‐Merino. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Breast Cancer and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact